Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
A case of a primary cutaneous plasmacytoma presenting in adolescence..
Am J Dermatopathol. 34(5), 537-40.
(2012).
(2018). A Case of a Paracardial Osteophyte Causing Atrial Compression..
Case Rep Med. 2016, 4325830.
(2016). Cartilaginous and osseous metaplasia with bone marrow formation in the aortic valve of a patient with giant cell aortitis..
Ann Thorac Surg. 81(5), 1877-9.
(2006). Carotid Intima-media Thickness, Paraoxonase-1 Gene Polymorphism, Inflammation and Oxidation Status in Children with Family History of Premature Cardiovascular Diseases.
Cardiology and Angiology: An International Journal. 5(2), 1 - 8.
(2016). Carotid intima-media thickness in patients with inflammatory bowel disease: a systematic review..
Angiology. 65(4), 284-93.
(2014). Carotid intima-media thickness as a target-organ damage and treatment-target: Need for a major revision?.
J Clin Hypertens (Greenwich). 20(2), 255-257.
(2018). Carotid baroreceptor stimulation for the treatment of resistant hypertension..
Int J Hypertens. 2011, 964394.
(2011). Carotid baroreceptor stimulation as a therapeutic target in hypertension and other cardiovascular conditions..
Expert Opin Ther Targets. 13(4), 413-25.
(2009). Carotid baroreceptor stimulation: a promising approach for the management of resistant hypertension and heart failure..
Curr Vasc Pharmacol. 12(1), 30-7.
(2014). The carotico-clinoid bar: A systematic review and meta-analysis of its prevalence and potential implications in cerebrovascular and skull base surgery..
World Neurosurg.
(2019). Carnitine status and lactate increase in patients with type I juvenile diabetes..
Minerva Pediatr. 62(6), 551-7.
(2010). Carney Complex: One More Entity with Skin and Bone Manifestations.
RadioGraphics. 35(1), 296 - 297.
(2015). Cardiοvascular diseases in pregnancy..
Am J Cardiovasc Dis. 2(2), 96-101.
(2012). Cardiovascular risk with DPP-4 inhibitors: latest evidence and clinical implications..
Ther Adv Drug Saf. 7(2), 36-8.
(2016). Cardiovascular risk with DPP-4 inhibitors: latest evidence and clinical implications.
Therapeutic Advances in Drug Safety. 7(2), 36 - 38.
(2016). Cardiovascular risk reduction with combination of anti-atherosclerotic medications in younger and older patients..
Curr Med Res Opin. 29(7), 791-2.
(2013). Cardiovascular risk prediction models with myocardial perfusion imaging in chronic kidney disease: ACCESSing digits or focusing on the patient?.
J Nucl Cardiol.
(2018). Cardiovascular risk in rheumatoid arthritis: assessment, management and next steps..
Ther Adv Musculoskelet Dis. 8(3), 86-101.
(2016). Cardiovascular risk in psoriatic arthritis: should we focus on hypertension and diabetes only?.
Clin Exp Rheumatol. 32(6), 995.
(2014). Cardiovascular Risk in Middle East Populations: A Call to Action..
Angiology. 66(9), 801-2.
(2015). Cardiovascular risk in adult patients with growth hormone (GH) deficiency and following substitution with GH--an update..
J Clin Endocrinol Metab. 99(1), 18-29.
(2014). Cardiovascular risk factors and estimated 10-year risk of fatal cardiovascular events using various equations in Greeks with metabolic syndrome..
Angiology. 61(1), 49-57.
(2010). Cardiovascular risk assessment in elderly individuals without overt CVD disease. Could traditional risk factors fit in all ages?.
J Clin Hypertens (Greenwich). 21(8), 1153-1154.
(2019). Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: An update..
World J Gastroenterol. 21(22), 6820-34.
(2015).